7th World Antibody Drug Conjugate (ADC) Berlin

7th World Antibody Drug Conjugate (ADC) Berlin is organized by Hanson Wade and would be held during Feb 20 - 22, 2017 at Maritim Proarte Hotel Berlin, Berlin, Germany. The target audience for this medical event for Heads of and Scientists in ADCs, Oncology, Antibody/Biologics, Clinical Development, Medicinal Chemistry.

The last 12 months has seen a staggering amount of progress in ADCs. There are now 50+ compounds in the clinic; with approval of Pfizer's Inotuzumab Ozogamicin expected later this year. Coupled with this, there is a bulging preclinical pipeline of 92 ADC's and counting.

Top 3 Benefits of Attending :
• Immerse yourself in cutting-edge ADC science and hear the latest data, insight and lessons learned to power the development of your lead candidate Covering every element of ADC discovery
• development, manufacturing and clinical programs this summit offers you an unrivalled breadth of content
• Unparalleled opportunity to catch-up with over 300 of your ADC colleagues and foster new industry connections

10 Reasons to Attend World ADC :
• Explore payloads with differentiated mechanisms of action for enhanced efficacy & overcome cancer resistance
•Minimise off target toxicities through antibody optimisation & alternative protein formats
• Improve your understanding of the impact of drug loading on biological activity of your ADC
• File a successful IND by effective characterisation of your ADC molecule and build a robust bioanalytical package
• Develop scalable, reproducible & safe processes with improved knowledge of process understanding
• Explore novel linker & site specific conjugation technologies which improve drug stability in vivo and intracellular localisation of payload in tumour cell
• Optimise clinical dosing regimes to minimise severe adverse events and cumulative toxicity
• Improve understanding of how single use technologies can reduce upfront capital costs of ADC manufacturing
• Overcome challenges of limited capacities & technical expertise and robustly outsource your ADC manufacturing to your chosen CMO
• Learn how to implement a novel model to quantify the bystander of your ADC in silico

This year's World ADC Berlin (20-22 February) program has been designed to reflect these progressive innovations developing next-generation ADCs. Bringing together 49 thought leaders in the ADC field; you will hear their lessons learned, discuss new data and debate your future opportunities. Attend this conference to access intelligence on the latest improvements in developing the next generation of clinically transformative ADCs. World ADC Berlin will help transform your ADC research - today.

Price :
Gold - conference and 2 workshops : EUR 3497
Silver - conference and 1 workshop: EUR 2998
Bronze - conference only: EUR 2499
Analytical and Bioanalytical day : EUR 1198
Workshops only : EUR 699

Speakers : Ulf Grawunder, Puja Sapra, Yves Baudat, Yves Baudat, Wayne Widdison, Tony Cano, Tok Han, Thomas Wickham, Steve Coats, Sophia Hober, Ron Lin, Robert Xin, Robert Kolakowski, Olivier Marcq, Olivier Heudi, Miro Eigemann, Mary Robinette, Martin Mattarella, Maria Elena Guadagno, Lucia D'Amico, Ling Xu, Kurt Gish, Judy Hsii, John Lambert, Joachim Krueger, Iontcho Vlahov, Guodong Chen, Gary Chen, Donglu Zhang, Dhaval Shah, David Satijn, Damon Meyer, Christoph Rader, Charles Dumontet, Chakrapani Subramanyam, Arnaud Delobel, Anette Sommer, Alain Beck, Dominik Schumacher, Jonas Helma, Justin Mason-Home, Ulrich Storz, Christine Sedlik, Norbert Sewald, Yannis-Nicolas Francois, Cong Wei, Roberto Depaz, Afsaneh Abdolzade-Bavil, Alex Lazar, Gillian Payne